These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25893217)

  • 1. HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure.
    Dampier W; Nonnemacher MR; Sullivan NT; Jacobson JM; Wigdahl B
    MOJ Immunol; 2014 Oct; 1(4):. PubMed ID: 25893217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics.
    Dampier W; Sullivan NT; Mell JC; Pirrone V; Ehrlich GD; Chung CH; Allen AG; DeSimone M; Zhong W; Kercher K; Passic S; Williams JW; Szep Z; Khalili K; Jacobson JM; Nonnemacher MR; Wigdahl B
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):950-960. PubMed ID: 29968495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients.
    Sullivan NT; Dampier W; Chung CH; Allen AG; Atkins A; Pirrone V; Homan G; Passic S; Williams J; Zhong W; Kercher K; Desimone M; Li L; C Antell G; Mell JC; Ehrlich GD; Szep Z; Jacobson JM; Nonnemacher MR; Wigdahl B
    Sci Rep; 2019 Nov; 9(1):17088. PubMed ID: 31745112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.
    Roychoudhury P; De Silva Feelixge H; Reeves D; Mayer BT; Stone D; Schiffer JT; Jerome KR
    BMC Biol; 2018 Jul; 16(1):75. PubMed ID: 29996827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.
    Lai M; Maori E; Quaranta P; Matteoli G; Maggi F; Sgarbanti M; Crucitta S; Pacini S; Turriziani O; Antonelli G; Heeney JL; Freer G; Pistello M
    J Virol; 2021 Nov; 95(23):e0135821. PubMed ID: 34549986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
    Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
    Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
    EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9: a tool to eradicate HIV-1.
    Bhowmik R; Chaubey B
    AIDS Res Ther; 2022 Dec; 19(1):58. PubMed ID: 36457057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.
    Chung CH; Allen AG; Atkins AJ; Sullivan NT; Homan G; Costello R; Madrid R; Nonnemacher MR; Dampier W; Wigdahl B
    Mol Ther Nucleic Acids; 2020 Sep; 21():965-982. PubMed ID: 32818921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic application of CRISPR/Cas9 technologies for HIV.
    Saayman S; Ali SA; Morris KV; Weinberg MS
    Expert Opin Biol Ther; 2015 Jun; 15(6):819-30. PubMed ID: 25865334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS.
    Yin C; Zhang T; Li F; Yang F; Putatunda R; Young WB; Khalili K; Hu W; Zhang Y
    AIDS; 2016 May; 30(8):1163-74. PubMed ID: 26990633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR/Cas9 library to map the HIV-1 provirus genetic fitness.
    Yoder KE
    Acta Virol; 2019; 63(2):129-138. PubMed ID: 31230441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9.
    Allen AG; Chung CH; Worrell SD; Nwaozo G; Madrid R; Mele AR; Dampier W; Nonnemacher MR; Wigdahl B
    Front Genome Ed; 2023; 5():1101483. PubMed ID: 37124096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of CRISPR/Cas9 Guide RNA Efficiency and Specificity Against Genetically Diverse HIV-1 Isolates.
    Sessions KJ; Chen YY; Hodge CA; Hudson TR; Eszterhas SK; Hayden MS; Howell AL
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):862-874. PubMed ID: 32640832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy.
    Link RW; Nonnemacher MR; Wigdahl B; Dampier W
    CRISPR J; 2018 Aug; 1(4):294-302. PubMed ID: 31021222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome editing strategies: potential tools for eradicating HIV-1/AIDS.
    Khalili K; Kaminski R; Gordon J; Cosentino L; Hu W
    J Neurovirol; 2015 Jun; 21(3):310-21. PubMed ID: 25716921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 cure strategies: why CRISPR?
    Atkins AJ; Allen AG; Dampier W; Haddad EK; Nonnemacher MR; Wigdahl B
    Expert Opin Biol Ther; 2021 Jun; 21(6):781-793. PubMed ID: 33331178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative Feedback Regulation of HIV-1 by Gene Editing Strategy.
    Kaminski R; Chen Y; Salkind J; Bella R; Young WB; Ferrante P; Karn J; Malcolm T; Hu W; Khalili K
    Sci Rep; 2016 Aug; 6():31527. PubMed ID: 27528385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects.
    Xu Y; Peng X; Zheng Y; Jin C; Lu X; Han D; Fu H; Chen C; Wu N
    Front Microbiol; 2021; 12():629153. PubMed ID: 34122355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.